NuScale's substantial liquidity of nearly $1.9 billion in cash and investments with zero debt as of mid-2026 provides a buffer against near-term insolvency despite quarterly cash burn of $55-65 million and revenue collapsing to $75,000 in Q2 after completing RoPower design work. Trader sentiment reflects persistent commercialization risks for its small modular reactor (SMR) technology, including unresolved power purchase agreements with the Tennessee Valley Authority and delays finalizing Romania's six-module deployment, even as NuScale holds the sole U.S. Nuclear Regulatory Commission design certification. Analyst downgrades and an 85-90% stock drop from 2025 peaks highlight execution hurdles versus faster-moving SMR rivals. Key near-term catalysts include Q3 earnings around November 5 and potential contract milestones that could shift licensing timelines or require further dilution.